The impact of crowdsourcing in modern drug discovery
- Pharmaceutical companies are among the top investors into research and development (R&D) globally, as product innovation is still the main growth driver for the industry and because the related complexities necessitate enormous R&D investments. The market demand for new medicines to be more efficacious or to provide better safety than existing drugs and the regulatory need to prove superiority in clinical trials are reasons why drug R&D is increasingly expensive and pharmaceutical companies need to manage extraordinarily high costs per approved new compound.
| Author of HS Reutlingen | Schuhmacher, Alexander |
|---|---|
| DOI: | https://doi.org/10.1080/17460441.2020.1751116 |
| Erschienen in: | Expert opinion on drug discovery |
| Publisher: | Taylor & Francis Group |
| Place of publication: | Abingdon |
| Document Type: | Journal article |
| Language: | English |
| Publication year: | 2020 |
| Tag: | crowdfunding; crowdsourcing; drug discovery; open innovation; open source; pharmaceutical industry; virtual R&D |
| Volume: | 15 |
| Issue: | 8 |
| Page Number: | 3 |
| First Page: | 865 |
| Last Page: | 867 |
| DDC classes: | 610 Medizin, Gesundheit |
| Open access?: | Nein |
